(reuters.com): When drugmakers fund studies of their own products, the results are much more likely to be positive than when the government picks up the bill, US researchers have said. They found that about 85 percent of industry-backed studies reported positive outcomes, compared to only half of those with federal funding.
Category: Articles
Click here